Quest Diagnostics' mobile specimen collection services provide flexibility and convenience for trial participants. Our expert teams ensure a seamless experience, enhancing patient recruitment and retention. https://lnkd.in/gTHxMH9h #MobilePhlebotomy #SpecimenCollection #QuestDiagnostics #TrialEfficiency
Quest Diagnostics BioPharma Services
Hospitals and Health Care
Secaucus, NJ 1,503 followers
Accelerating your path to market.
About us
When you choose Quest Diagnostics as your partner in BioPharma Services, you get more than lab testing. From development of companion diagnostics and clinical trial testing to successful commercialization of your innovative solutions, we’re here to help you hit every milestone. Our market access is unparalleled—4,000+ tests run 500+ million times annually, and 58 billion lab results—and we leverage our world-leading staff of MDs and PhDs and relationships with leading In Vitro Diagnostics (IVD) partners around the world to offer a smarter approach to accelerating your path to market. Quest Diagnostics BioPharma Services. Let’s get started.
- Website
-
https://www.questdiagnostics.com/business-solutions/life-sciences
External link for Quest Diagnostics BioPharma Services
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Secaucus, NJ
Updates
-
Lab testing is one early point in which potentially eligible patients can be identified for enrollment in a clinical trial. We utilize diagnostic, biomarker, and demographic data to identify and help recruit individuals who meet your eligibility criteria. https://lnkd.in/gkEQjSHE #PatientRecruitment #ClinicalTrialEnrollment #QuestHealthcareAnalyticsSolutions #ClinicalTrials
-
-
Developing the cardiometabolic therapies of the future can be a complex and challenging process. We can help you design and execute clinical trials, navigate regulatory requirements, and ensure that your medicines are available to patients on day-one. Learn more: https://lnkd.in/gsPdvCWj #CardiometabolicTherapies #ClinicalTrials #PrecisionMedicine
-
-
BD and Quest Diagnostics announced a global collaboration agreement to develop, manufacture and commercialize flow cytometry-based companion diagnostics (CDx) intended to help select the best treatment for patients with cancer and other diseases. This strategic collaboration with BD will combine our expertise in developing and validating biomarkers and assays with BD's leadership in flow cytometry to offer a fully integrated solution on a larger scale," said Bill Finger, vice president and general manager, BioPharma Services, Quest Diagnostics. "Together, we can bring novel companion diagnostics to market that will enable more precise health care, to potentially improve patient outcomes and reduce health care costs." Learn more: https://lnkd.in/e2MPuF_u
-
No matter your therapeutic area, we can provide regulatory strategies, manage pre-submission meetings with regulatory bodies, and assist with regulatory pathways. Learn more. https://lnkd.in/gdwdKgiR #IVD #MedTech #IVDClinicialTrials
From analytical validation through commercialization
questdiagnostics.com
-
Enhance your clinical trials with Quest Diagnostics' sponsored testing solutions. Our extensive network ensures effective and reliable testing, helping you achieve better trial outcomes. Partner with Quest to optimize your research and development. https://lnkd.in/ganiTZ2s #SponsoredTesting #PharmaSolutions #QuestDiagnostics #ClinicalResearch
-
-
Support commercial effectiveness and patient care with Quest Diagnostics' real-time commercial alerts. Schedule timely alerts for biomarker populations to ensure you have the insights needed to drive better outcomes. Trust Quest for actionable data. Learn more: https://lnkd.in/gc-tXfpK #CommercialAlerts #Biomarkers #QuestDiagnostics #PatientCare
-
-
With the support of the wider Quest Diagnostics infrastructure, collaborate with our specialized oncology teams. They're adept at both therapeutic and diagnostic development, all centered around a key goal: ensuring patients can access your essential therapy. Learn more. https://lnkd.in/gGydrXAc #PrecisionOncology #BioPharma #PrecisionMedicine
-
-
As the pharmaceutical landscape evolves with the rise of specialty drugs and injectables, overcoming adherence challenges is critical. These medications, essential for treating chronic and complex diseases, come with unique hurdles such as complex regimens, administration difficulties, and high costs.Gain a deeper understanding of medication adherence for specialty medications with our white paper. Download today! https://lnkd.in/gcuRZRMH #PatientEngagement #MedicationAdherence #PatientSupport
White paper - Enhancing adherence for specialty medications
questdiagnostics.com
-
Are you ready to overcome the challenges of CDx commercialization? Our white paper, 'CDx Market Access: The Path to Precision Medicine Success,' provides insights based on real-world experiences. Gain a competitive edge taking your precision medicine to market. Download the white paper today! https://lnkd.in/gEr5fTzJ #CDx #CompanionDiagnostics #PrecisionMedicine
CDx Market Access
questdiagnostics.com